Predictive oncology announces new chief executive officer raymond f. vennare to lead company growth

Eagan, minn., oct. 20, 2022 (globe newswire) -- predictive oncology (nasdaq: poai) is pleased to announce the appointment of raymond f. vennare as chief executive officer and chairman of the board, effective nov. 1.
POAI Ratings Summary
POAI Quant Ranking